# Safety Study of Intravenous MiraMSC in Older Adults With Mild to Moderate Frailty Syndrome

> **NCT07705464** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Miracle Biomedical Co., Ltd.** · enrollment: 12 (estimated)

## Conditions studied

- Frailty

## Interventions

- **DRUG:** MiraMSC-FS-001

## Key facts

- **NCT ID:** NCT07705464
- **Lead sponsor:** Miracle Biomedical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-12-01
- **Primary completion:** 2028-06-30
- **Final completion:** 2028-06-30
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2026-07-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07705464

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07705464, "Safety Study of Intravenous MiraMSC in Older Adults With Mild to Moderate Frailty Syndrome". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07705464. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*